Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children

PHASE4CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

June 7, 2010

Primary Completion Date

November 26, 2010

Study Completion Date

November 26, 2010

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Engerix™-B

Intramuscular, single dose

Trial Locations (11)

974 01

GSK Investigational Site, Banská Bystrica

026 01

GSK Investigational Site, Dolný Kubín

018 41

GSK Investigational Site, Dubnica nad Váhom

036 01

GSK Investigational Site, Martin

949 01

GSK Investigational Site, Nitra

018 51

GSK Investigational Site, Nová Dubnica

940 01

GSK Investigational Site, Nové Zámky

020 01

GSK Investigational Site, Púchov

048 01

GSK Investigational Site, Rožňava

075 01

GSK Investigational Site, Trebišov

953 01

GSK Investigational Site, Zlaté Moravce

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY